Improving diagnosis and care for COPD flare-ups
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are in the emergency room with a COPD flare-up (worsening shortness of breath, more coughing, or more mucus than usual).
- You or a family member can agree to participate in the study.
- You do not have a blood clot in your lung, severe sepsis, or a very short life expectancy.
- Study staff (not your regular doctors) will ask you to join and explain everything.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This trial tests whether special care from a nurse can help people hospitalized for a COPD flare-up breathe better and recover faster. It may be a good fit if you are 40 or older, have moderate or worse shortness of breath, and are stable enough for the nursing program.
This trial studies a coordinated (multidisciplinary) care program for people with severe COPD who were recently hospitalized for worsening breathing symptoms. It may help reduce future flare-ups and improve day-to-day breathing by coordinating multiple types of care in a COPD center.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This trial compares customized durations of antibiotics to standard durations for treating acute worsening of COPD. It aims to see if stopping antibiotics early when symptoms improve is as effective as the usual fixed course.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.